UGqirha Zhou Yingjun, u-CEO we-Geneham Pharmaceutical uthatha inxaxheba ekubhaleni iphepha elimhlophe lase-China kwizityalo ezikhutshiweyo

Iindaba

UGqirha Zhou Yingjun, u-CEO we-Geneham Pharmaceutical uthatha inxaxheba ekubhaleni iphepha elimhlophe lase-China kwizityalo ezikhutshiweyo

Ekuqaleni kwee-1980, iziphumo ebezingalindelekanga zeekhemikhali zabangela iliza elikhulu "lokukhuthaza nokubuyela kwindalo"; ngo-1994, i-United States yapasisa umthetho “Umthetho weDiary Supplement Health and Education Act (DSHEA)”, nowamisela ngokusesikweni ubume obusemthethweni bokukhutshwa kwezityalo njengezinto zokutya ezingafunekiyo. Ukusukela ngoko, ukuthengiswa kwezityalo kwihlabathi liphela kuyanda kwaye iChina iye yaba ngoyena mthengisi mkhulu emhlabeni ngokuxhomekeka kubutyebi bendalo bayo.

Ukulungiselela ukumisela emgangathweni kunye nokukhokela kuphuhliso olusempilweni lwezicatshulwa zezityalo ngobuchule, iZiko loLwazi leKhomishini yoPhuculo lweLizwe kunye neKhomishini yoTshintsho, iYunivesithi yezolimo yaseHunan, iChenguang Biotech Group Co, Ltd njl njl ngaphezulu kweeyunithi ezili-10 neenkampani zenza iqela lokudibanisa, usungule ngokusesikweni umsebenzi wophando kumzi mveliso wezicatshulwa zezityalo, nasekuqulunqeni iphepha elimhlophe lezityalo zase China (i-Chinese Traditional Medicine) ishishini lezicatshulwa (apha ekuthiwa "liphepha elimhlophe"). IGeneham Pharmaceutical Co, Ltd- njengelungu lezityalo zase China ezikhupha umanyano lweshishini kunye ne-CEO yethu, uGqirha Zhou Yingjun -ngusihlalo we-Pharmaceutical Chemistry Department, ikholeji ye-Pharmacy kunye neNtloko yeCandelo lokuFundisa noPhando, iSebe lezendalo lamachiza , ICentral South University ithathe inxaxheba ekubhaleni iphepha eliMhlophe laseShishini lezoTyalo lweZityalo zaseChina.


Ixesha Post: Dec-01-2020

Iingxelo

Bhala umyalezo wakho apha uze uyithumele kuthi